EUVIMEDEUVIMED entdecken
Crossref

Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain

Dina Najjari-Jamal, Angels Rovirosa, Marta Gimeno-Morales, Katarina Majercakova, Maria Sánchez, Sonia Garcia, Diana Guevara, Teresa Muñoz, Cristina De la Fuente, Soraya Micó, Milica Stefanovic, Raul Matute und 1 weitere

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03804-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Dina Najjari-Jamal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Department, Catalan Institute of Oncology (ICO), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. dnajjari@icon…. Hauptthemen laut MEDLINE: Re-Irradiation, Genital Neoplasms, Female, Practice Patterns, Physicians', Neoplasm Recurrence, Local. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Given the lack of standardisation in gynecological cancer reirradiation, the Gyneacologial Radiation Oncology (GINECOR) working group on behalf of the Spanish Society of Radiation Oncology (SEOR), works towards to inquire the current state of reirradiation practices among the radiation oncology departments in Spain. METHODS: An online 37-question survey was sent to all GINECOR members, representing most Spanish centers. The survey addressed general aspects of reirradiation, including experience, reirradiation sites, and techniques used. It included seven clinical case scenarios on reirradiation, and a final section on technical aspects of external beam radiotherapy (EBRT) and brachytherapy (BT) treatment. Descriptive statistics were used for data analysis. RESULTS: Out of 58 centers, 29 responded, with 51.7% performing ≥ 5 reirradiation cases annually. While most centers offer multiple techniques, only 16/29 have access to BT. For in-field local relapse with surgery contraindicated, 79.3% performed BT in endometrial cancer, but only 27.5% treated with BT in cervical cancer recurrence. In this case, 17.2% used SBRT. For endometrial and cervical cancer, 44.8% and 65.4% of centers prescribed doses based on organ-at-risk tolerance, respectively. For pelvic wall/parametrial in-field relapse, 46.4% of the centres reirradiated with stereotactic body radiotherapy (SBRT), and 32.1% with BT. In nodal reirradiation, SBRT was preferred by 90% of centers. Variability was observed in target volume definitions for EBRT and proton therapy. CONCLUSIONS: Reirradiation for gynecological cancer remains unstandardized, presenting significant challenges in clinical practice. To improve reirradiation protocols in gynecological cancer, the GINECOR working group is currently conducting a systematic review and formulating Delphi recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Re-IrradiationGenital Neoplasms, FemalePractice Patterns, Physicians'Neoplasm Recurrence, LocalRadiation OncologyHumansFemaleSpainBrachytherapySurveys and Questionnaires

Stichwörter der Autor:innen

BrachytherapyGynecological cancerRadiotherapyReirradiationSurvey

Autor:innen und Institutionen

  • Radiation Oncology Department, Catalan Institute of Oncology (ICO), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. dnajjari@iconcologia.net.
  • Radiation Oncology Department, Hospital Cl¡nic IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Radiation Oncology Department, Cancer Center Clinica, Universidad de Navarra, University of Navarre, Pamplona/Madrid, Spain.
  • Radiation Oncology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Radiation Oncology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Radiation Oncology Department, Reina Sofía University Hospital, Córdoba, Spain.

Zitieren

APA

Najjari-Jamal, D., Rovirosa, A., Gimeno-Morales, M., Majercakova, K., Sánchez, M., Garcia, S., Guevara, D., Muñoz, T., De la Fuente, C., Micó, S., Stefanovic, M., Matute, R., & Córdoba, S. (2024). Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03804-x

Vancouver

Najjari-Jamal D, Rovirosa A, Gimeno-Morales M, Majercakova K, Sánchez M, Garcia S, et al. Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03804-x

BibTeX
@article{NajjariJamal2024,
  author = {Najjari-Jamal, Dina and Rovirosa, Angels and Gimeno-Morales, Marta and Majercakova, Katarina and Sánchez, Maria and Garcia, Sonia and Guevara, Diana and Muñoz, Teresa and De la Fuente, Cristina and Micó, Soraya and Stefanovic, Milica and Matute, Raul and Córdoba, Sofia},
  title = {Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03804-x}
}
Kostenlos starten →